Clinical Trial Update: Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is studying islet alpha cell function in patients with Type 2 Diabetes and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: RECRUITING